Table 1.
Weight loss, ≥2.0 kg | Weight change, within 2.0 kg | Weight gain, 2.0-5.9 kg | Weight gain, 6.0-9.9 kg | Weight gain, 10.0-19.9 kg | Weight gain, ≥20.0 kg | |
---|---|---|---|---|---|---|
Age, years* | 39.3 (4.7) | 39.2 (4.7) | 39.5 (4.6) | 40.0 (4.6) | 40.6 (4.6) | 41.2 (4.5) |
Body mass index, kg/m2 | 22.0 (3.6) | 21.2 (2.7) | 21.9 (2.5) | 23.4 (2.7) | 26.1 (3.3) | 33.7 (6.0) |
BMI at age 18 | 24.5 (4.8) | 21.1 (2.7) | 20.4 (2.5) | 20.4 (2.6) | 20.7 (3.0) | 22.3 (3.7) |
Physical activity, METsa | 26.8 (32.9) | 25.1 (31.3) | 23.2 (28.8) | 21.3 (26.8) | 19.4 (25.5) | 16.4 (22.8) |
Smoking status | ||||||
- never, % | 61.7 | 67.8 | 68.9 | 68.0 | 68.1 | 69.4 |
- past, % | 25.3 | 24.3 | 23.7 | 24.8 | 24.2 | 23.9 |
- current, % | 13.0 | 7.9 | 7.4 | 7.2 | 7.7 | 6.7 |
History of diabetes, % | 1.4 | 0.8 | 0.9 | 0.8 | 1.3 | 3.2 |
History of hypertension, % | 2.4 | 2.1 | 2.2 | 3.1 | 5.3 | 13.4 |
History of hypercholesterolemia, % | 5.9 | 5.7 | 6.1 | 7.7 | 10.9 | 17.4 |
Alternate Healthy Eating Index score | 53.1 (11.3) | 52.1 (11.2) | 51.0 (10.8) | 49.9 (10.5) | 48.6 (10.3) | 46.3 (10.2) |
Regular aspirin use, 1995,† % | 11.5 | 10.8 | 10.8 | 10.3 | 10.8 | 12.0 |
Premenopausal, % | 93.2 | 94.0 | 94.0 | 93.8 | 92.6 | 91.4 |
Current menopausal hormone,‡ % therapy,‡ % | 4.8 | 4.5 | 4.5 | 4.7 | 5.7 | 6.5 |
Race (white), % | 96.9 | 96.7 | 96.3 | 95.6 | 94.7 | 95.1 |
BMI, body mass index; MET, metabolic equivalent of tasks.
All values other than age are standardized to the age distrubition of the study population. Values are means (SD) unless stated otherwise.
Physical activity was defined according to expended MET-hours/week (see Methods).
Regular aspirin use was defined as the regular use of at least 2 aspirin pills per week.
Among postmenopausal participants.